Effects of Pranlukast, a Leukotriene Receptor Antagonist, on Airway Inflammation in Mild Asthmatics

REFERENCES

• Lange P., Parner J., Vestbo J., Schnohr P., Jensen G. A. 15-Year Follow-up Study of Ventilatory Function in Adults with Asthma. N. Engl. J. Med. 1998; 339: 1194
   PubMed Web of Science ®Google Scholar
• Peat J. K., Woolcock A. J., Cullen K. Rate of Decline of Lung Function in Subjects with Asthma. Eur. J. Respir. Dis. 1987; 70: 171
   PubMedGoogle Scholar
• James A. L., Pare P. D., Hogg J. C. The Mechanics of Airway Narrowing in Asthma. Am. Rev. Respir. Dis. 1989; 139: 242
   PubMed Web of Science ®Google Scholar
• Jeffery P. K., Godfrey R. W., Adelroth E., Nelson F., Rogers A., Johansson S. A. Effects of Treatment on Airway Inflammation and Thickening of Basement Membrane Reticular Collagen in Asthma: A Quantitative Light and Electron Microscopic Study. Am. Rev. Respir. Dis. 1992; 145(4 Pt. 1)890
   PubMedGoogle Scholar
• Ohno I., Nitta Y., Yamauchi K., Hoshi H., Honma M., Woolley K., O'Byrne P., Dolovich J., Jordana M., Tamura G., Tanno Y., Shirato K. Eosinophils as a Potential Source of Platelet-Derived Growth Factor B-Chain (PDGF-B) in Nasal Polyposis and Bronchial Asthma. Am. J. Respir. Cell. Mol. Biol. 1995; 13: 639
   PubMed Web of Science ®Google Scholar
• Ohno I., Nitta Y., Yamauchi K., Hoshi H., Honma M., Woolley K., O'Byrne P., Tamura G., Jordana M., Shirato K. Transforming Growth Factor Beta 1 (TGF Beta 1) Gene Expression by Eosinophils in Asthmatic Airway Inflammation. Am. J. Respir. Cell Mol. Biol. 1996; 15: 404
   PubMed Web of Science ®Google Scholar
• Dompeling E., van Schayck C. P., van Grunsven P. M., van Herwaarden C. L., Akkermans R., Molema J., Folgering H., van Weel C. Slowing the Deterioration of Asthma and Chronic Obstructive Pulmonary Disease Observed During Bronchodilator Therapy by Adding Inhaled Corticosteroids: A 4-Year Prospective Study. Ann. Int. Med. 1993; 118: 770
   PubMed Web of Science ®Google Scholar
• Haahtela T., Jarvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Selroos O., Sovijarvi A., Stenius-Aarniala B., Svahn T., Tammivaara R., Laitinen L. A. Effects of Reducing or Discontinuing Inhaled Budesonide in Patients with Mild Asthma. N. Engl. J. Med. 1994; 331: 700
   PubMed Web of Science ®Google Scholar
• O'Byrne P. M., Inman M. D. Induced Sputum to Assess Airway Inflammation in Asthma. Eur. Respir. J. 1996; 9: 2435
   PubMed Web of Science ®Google Scholar
• Kharitonov S. A., Yates D., Robbins R. A., Logan-Sinclair R., Shinebourne E. A., Barnes P. J. Increased Nitric Oxide in Exhaled Air of Asthmatic Patients. Lancet 1994; 343: 133
   PubMed Web of Science ®Google Scholar
• Howarth P. H., Redington A. E., Springall D. R., Martin U., Bloom S. R., Polak J. M., Holgate S. T. Epithelially Derived Endothelin and Nitric Oxide in Asthma. Int. Arch. Allergy Immunol. 1995; 107: 228
   PubMed Web of Science ®Google Scholar
• Kanazawa H., Shoji S., Yamada M., Fujii T., Kawaguchi T., Kudoh S., Hirata K., Yoshikawa J. Increased Levels of Nitric Oxide Derivatives in Induced Sputum in Patients with Asthma. J. Allergy Clin. Immunol. 1997; 99: 624
   PubMed Web of Science ®Google Scholar
• Nakamura Y., Hoshino M., Sim J. J., Ishii K., Hosaka K., Sakamoto T. Effect of the Leukotriene Receptor Antagonist Pranlukast on Cellular Infiltration in the Bronchial Mucosa of Patients with Asthma. Thorax 1998; 53: 835
   PubMed Web of Science ®Google Scholar
• Wenzel S. E. Should Antileukotriene Therapies Be Used Instead of Inhaled Corticosteroids in Asthma?. No. Am. J. Respir. Crit. Care Med. 1998; 158: 1699
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood Institute. NHLBI/WHO Workshop Global Strategy for Asthma Management and Prevention, Report. Publication No. 95-3659, Global Initiative for Asthma. National Heart, Lung, and Blood Institute, Bethesda, MD 1995
   Google Scholar
• Pin I., Gibson P. G., Kolendowicz R., Girgis-Gabardo A., Denburg J. A., Hargreave F. E., Dolovich J. Use of Induced Sputum Cell Counts to Investigate Airway Inflammation in Asthma. Thorax 1992; 47: 25
   PubMed Web of Science ®Google Scholar
• Gibson P. G., Girgis-Gabardo A., Morris M. M., Mattoli S., Kay J. M., Dolovich J., Denburg J., Hargreave F. E. Cellular Characteristics of Sputum from Patients with Asthma and Chronic Bronchitis. Thorax 1989; 44: 693
   PubMed Web of Science ®Google Scholar
• Kharitonov S. A., Yates D. H., Barnes P. J. Inhaled Glucocorticoids Decrease Nitric Oxide in Exhaled Air of Asthmatic Patients. Am. J. Respir. Crit. Care Med. 1996; 153: 454
   PubMed Web of Science ®Google Scholar
• Fahy J. V., Boushey H. A. Effect of Low-Dose Beclomethasone Dipropionate on Asthma Control and Airway Inflammation. Eur. Respir. J. 1998; 11: 1240
   PubMed Web of Science ®Google Scholar
• Noonan M. J., Chervinsky P., Brandon M., Zhang J., Kundu S., McBurney J., Reiss T. F. Montelukast, a Potent Leukotriene Receptor Antagonist, Causes Dose-Related Improvements in Chronic Asthma. Montelukast Asthma Study Group. Eur. Respir. J. 1998; 11: 1232
   Google Scholar
• Altman L. C., Munk Z., Seltzer J., Noonan N., Shingo S., Zhang J., Reiss T. F. A Placebo-Controlled, Dose-Ranging Study of Montelukast, a Cysteinyl Leukotriene-Receptor Antagonist. Montelukast Asthma Study Group. J. Allergy Clin. Immunol. 1998; 102: 50
   PubMed Web of Science ®Google Scholar
• Underwood D. C., Osborn R. R., Newsholme S. J., Torphy T. J., Hay D. W. Persistent Airway Eosinophilia After Leukotriene (LT) D4 Administration in the Guinea Pig: Modulation by the LTD4 Receptor Aantagonist, Pranlukast, or an Interleukin-5 Monoclonal Antibody. Am. J. Respir. Crit. Care Med. 1996; 154(4 Pt. 1)850
   PubMed Web of Science ®Google Scholar
• Fujimoto K., Kubo K., Matsuzawa Y., Sekiguchi M. Eosinophil Cationic Protein Levels in Induced Sputum Correlate with the Severity of Bronchial Asthma. Chest 1997; 112: 1241
   PubMed Web of Science ®Google Scholar
• Minshall E. M., Leung D. Y., Martin R. J., Song Y. L., Cameron L., Ernst P., Hamid Q. Eosinophil-Associated TGF-beta1 mRNA Expression and Airways Fibrosis in Bronchial Asthma. Am. J. Respir. Cell Mol. Biol. 1997; 17: 326
   PubMed Web of Science ®Google Scholar
• Busse W., Elias J., Sheppard D., Banks-Schlegel S. Airway Remodeling and Repair. Am. J. Respir. Crit. Care Med. 1999; 160: 1035
   PubMed Web of Science ®Google Scholar
• Alving K., Weitzberg E., Lundberg J. M. Increased Amount of nitric Oxide in Exhaled Air of Asthmatics. Eur. Respir. J. 1993; 6: 1368
   PubMed Web of Science ®Google Scholar
• Persson M. G., Zetterstrom O., Agrenius V., Ihre E., Gustafsson L. E. Single-Breath Nitric Oxide Measurements in Asthmatic Patients and Smokers. Lancet 1994; 343: 146
   PubMed Web of Science ®Google Scholar
• Hamid Q., Springall D. R., Riveros-Moreno V., Chanez P., Howarth P., Redington A., Bousquet J., Godard P., Holgate S., Polak J. M. Induction of Nitric Oxide Synthase in Asthma. Lancet 1993; 342: 1510
   PubMed Web of Science ®Google Scholar
• Barnes P. J., Liew F. Y. Nitric Oxide and Asthmatic Inflammation. Immunology Today 1995; 16: 128
   PubMedGoogle Scholar
• Humbert M., Ying S., Corrigan C., Menz G., Barkans J., Pfister R., Meng Q., Van Damme J., Opdenakker G., Durham S. R., Kay A. B. Bronchial Mucosal Expression of the Genes Encoding Chemokines RANTES and MCP-3 in Symptomatic Atopic and Nonatopic Asthmatics: Relationship to the Eosinophil-Active Cytokines Interleukin (IL)-5, Granulocyte Macrophage-Colony-Stimulating Factor, and IL-3. Am. J. Respir. Cell Mol. Biol. 1997; 16: 1
   PubMed Web of Science ®Google Scholar
• Lamkhioued B., Renzi P. M., Abi-Younes S., Garcia-Zepada E. A., Allakhverdi Z., Ghaffar O., Rothenberg M. D., Luster A. D., Hamid Q. Increased Expression of Eotaxin in Bronchoalveolar Lavage and Airways of Asthmatics Contributes to the Chemotaxis of Eosinophils to the Site of Inflammation. J. Immunol. 1997; 159: 4593
   PubMed Web of Science ®Google Scholar